Published in Adv Prostaglandin Thromboxane Res on January 01, 1980
Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care (2001) 2.11
Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab (1992) 1.62
Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab (2000) 1.45
Glucagon secretion in diabetic patients with idiopathic haemochromatosis. Diabetologia (1977) 1.42
Presence of pancreatic glucagon in the portal plasma of human neonates. Differences in the insulin and glucagon responses to glucose between normal infants and infants from diabetic mothers. Diabetologia (1972) 1.15
Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care (1991) 1.12
Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study. Eur J Clin Pharmacol (1986) 1.05
Factors controlling gastric-glucagon release. J Clin Invest (1977) 1.02
Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc Soc Exp Biol Med (1970) 0.98
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia (1983) 0.98
Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study. Fertil Steril (1986) 0.96
Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab (1994) 0.95
Growth hormone, cortisol, and glucagon concentrations during plasma free fatty acid depression: different effects of nicotinic acid and an adenosine derivative (BM 11.189). J Clin Endocrinol Metab (1983) 0.93
Mechanisms involved in the exercise-induced increase in glucagon secretion in rats. Diabetes (1974) 0.92
Plasma glucagon levels in normal women during pregnancy. Diabetologia (1975) 0.90
Catecholamines and exercise-induced glucagon and fatty acid mobilization in the rat. Am J Physiol (1975) 0.89
Effects of pulsatile delivery of insulin and glucagon in humans. Am J Physiol (1989) 0.88
Letter: Potentiation of hypoglycemic effect of sulfonylureas by clofibrate. N Engl J Med (1976) 0.88
Glucagon and diabetes: a reappraisal. Diabetologia (1979) 0.88
Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog. Metabolism (1975) 0.88
Insulin sensitivity, clearance and release in kininogen-deficient rats. Exp Physiol (1999) 0.87
Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Diabetes Care (1984) 0.87
Glucose and insulin in the regulation of glucagon release from the isolated perfused dog stomach. Endocrinology (1978) 0.87
Renal handling of endogenous glucagon in the dog: comparison with insulin. Metabolism (1974) 0.86
Biological properties of a transplantable islet-cell tumor of the golden hamster. 3. Electron microscopic studies. Diabetes (1968) 0.86
Effect of dog jejunum "glucagon-like immunoreactive material" on adipose tissue metabolism. Horm Metab Res (1969) 0.86
The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Diabete Metab (1988) 0.86
Metabolic adaptations in post-exercise recovery. Clin Physiol (1982) 0.84
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci (Lond) (1991) 0.84
A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin. Diabetologia (1983) 0.84
Biological properties of a transplantable islet-cell tumor of the golden hamster. II. Insulin content of the tumor and some metabolic characteristics of the tumor-bearing animals. Diabetes (1967) 0.84
Fate of exogenous glucose during exercise of different intensities in humans. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.83
Plasma glucagon after kidney exclusion: experiments in somatostatin-infused and in eviscerated dogs. Metabolism (1976) 0.83
Muscular exercise and pancreatic function in rats. Isr J Med Sci (1972) 0.83
Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man. Diabetes (1984) 0.82
Stimulation of insulin secretion after prostaglandin PGE 1 in the anesthetized dog. Biochem Pharmacol (1973) 0.82
[Stimulation by carbamylcholine of dog gastric-glucagon release (author's transl) (proceedings)]. Ann Endocrinol (Paris) (1979) 0.82
Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab (1998) 0.82
Effect of oleic acid on insulin secretion by the isolated perfused rat pancreas. Diabetologia (1979) 0.82
Angioplastic necrolytic migratory erythema. Unique association of necrolytic migratory erythema, extensive angioplasia, and high molecular weight glucagon-like polypeptide. Am J Dermatopathol (1982) 0.81
Retinopathy, but not neuropathy, is influenced by the level of residual endogenous insulin secretion in type 2 diabetes. Diabete Metab (1995) 0.81
Metabolic adaptation to prolonged exercise in severely obese subjects. Int J Obes (1983) 0.80
Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetes. Diabetes Metab Res Rev (2001) 0.80
Independance of glucagon and insulin handling by the isolated perfused dog kidney. Diabetologia (1976) 0.80
Lipids and lipoproteins in chronic uraemia. A study of the influence of regular haemodialysis. Eur J Clin Invest (1976) 0.80
Insulin oscillations per se do not affect glucose turnover parameters in normal man. J Clin Endocrinol Metab (1986) 0.80
Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women. Climacteric (1999) 0.80
Hormonal and metabolic adaptation to protein-supplemented fasting in obese subjects. Int J Obes (1982) 0.79
Cardiovascular effects of intravenous tolmesoxide in hypertensive patients. Arch Int Pharmacodyn Ther (1981) 0.79
[Bronchial reactivity in diabetic patients]. Rev Mal Respir (1997) 0.79
Effect of insulin on glucagon enhanced lipolysis in vitro. Diabetologia (1969) 0.79
Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. Thymus (1993) 0.79
Interrelationships glucagon-adrenergic system in experimental and clinical conditions. Arch Int Pharmacodyn Ther (1968) 0.78
Pharmacological compounds affecting plasma glucagon levels in rats. Biochem Pharmacol (1976) 0.78
Effect of ouabain on insulin secretion in the anesthetized dog. Biochem Pharmacol (1972) 0.78
Vagal stimulation and its role in eliciting gastrin but not glucagon release from the isolated perfused dog stomach. Gut (1978) 0.78
Pharmacological treatment of the obese diabetic patient. Diabete Metab (1994) 0.78
Inhibition by somatostatin of carbamylcholine-induced gastrin and glucagon release from the isolated perfused canine stomach. Gut (1981) 0.78
Pituitary-testicular axis in diabetic men with and without sexual impotence. Diabete Metab (1978) 0.78
Influence of metformin on arginine-induced glucagon secretion in human diabetes. Diabete Metab (1975) 0.78
Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats. Br J Pharmacol (2001) 0.78
Effect of L8027, a new potent inhibitor of prostaglandin biosynthesis, on the metabolism and response to glucagon of rat adipose tissue. Biochem Pharmacol (1974) 0.78
[Advantages of pulsatile administration of human insulin on endogenous pancreatic secretion in the normal subject and in type 1 diabetics]. Ann Med Interne (Paris) (1988) 0.77
Possible role of endogenous prostaglandins in glucagon secretion by isolated guinea-pig islets. Diabetologia (1978) 0.77
Historical and methodological aspects of computer-assisted medical history-taking. Med Inform (Lond) (1986) 0.77
Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man. Arzneimittelforschung (1976) 0.77
The breakfast tolerance test: a return to physiology. Diabete Metab (1976) 0.77